BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 17560735)

  • 1. Impact of radiation-induced xerostomia on quality of life after primary radiotherapy among patients with head and neck cancer.
    Jellema AP; Slotman BJ; Doornaert P; Leemans CR; Langendijk JA
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):751-60. PubMed ID: 17560735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy.
    Langendijk JA; Doornaert P; Verdonck-de Leeuw IM; Leemans CR; Aaronson NK; Slotman BJ
    J Clin Oncol; 2008 Aug; 26(22):3770-6. PubMed ID: 18669465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matched case-control study of quality of life and xerostomia after intensity-modulated radiotherapy or standard radiotherapy for head-and-neck cancer: initial report.
    Jabbari S; Kim HM; Feng M; Lin A; Tsien C; Elshaikh M; Terrel JE; Murdoch-Kinch C; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):725-31. PubMed ID: 16199308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a nonrandomized prospective study using a standardized follow-up program.
    Vergeer MR; Doornaert PA; Rietveld DH; Leemans CR; Slotman BJ; Langendijk JA
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):1-8. PubMed ID: 19111400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postradiotherapy quality of life for head-and-neck cancer patients is independent of xerostomia.
    Ringash J; Warde P; Lockwood G; O'Sullivan B; Waldron J; Cummings B
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1403-7. PubMed ID: 15817343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of life as a survival predictor for patients with advanced head and neck carcinoma treated with radiotherapy.
    Fang FM; Liu YT; Tang Y; Wang CJ; Ko SF
    Cancer; 2004 Jan; 100(2):425-32. PubMed ID: 14716781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between saliva production and quality of life measurements in head and neck cancer patients treated with intensity-modulated radiotherapy.
    Scrimger R; Kanji A; Parliament M; Warkentin H; Field C; Jha N; Hanson J
    Am J Clin Oncol; 2007 Jun; 30(3):271-7. PubMed ID: 17551304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of pilocarpine during radiation therapy: results of RTOG 97-09, a phase III randomized study in head and neck cancer patients.
    Scarantino C; LeVeque F; Swann RS; White R; Schulsinger A; Hodson DI; Meredith R; Foote R; Brachman D; Lee N
    J Support Oncol; 2006 May; 4(5):252-8. PubMed ID: 16724649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life and salivary output in patients with head-and-neck cancer five years after radiotherapy.
    Braam PM; Roesink JM; Raaijmakers CP; Busschers WB; Terhaard CH
    Radiat Oncol; 2007 Jan; 2():3. PubMed ID: 17207274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of nutrition on outcome: a prospective randomized controlled trial in patients with head and neck cancer undergoing radiotherapy.
    Ravasco P; Monteiro-Grillo I; Marques Vidal P; Camilo ME
    Head Neck; 2005 Aug; 27(8):659-68. PubMed ID: 15920748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiotherapy alone, versus radiotherapy with amifostine 3 times weekly, versus radiotherapy with amifostine 5 times weekly: A prospective randomized study in squamous cell head and neck cancer.
    Jellema AP; Slotman BJ; Muller MJ; Leemans CR; Smeele LE; Hoekman K; Aaronson NK; Langendijk JA
    Cancer; 2006 Aug; 107(3):544-53. PubMed ID: 16804929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretreatment factors significantly influence quality of life in cancer patients: a Radiation Therapy Oncology Group (RTOG) analysis.
    Movsas B; Scott C; Watkins-Bruner D
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):830-5. PubMed ID: 16564646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial.
    Pow EH; Kwong DL; McMillan AS; Wong MC; Sham JS; Leung LH; Leung WK
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):981-91. PubMed ID: 17145528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical investigation: Reliability and validity of the Japanese version of quality of life radiation therapy instrument (QOL-RTI) for Japanese patients with head and neck malignancies.
    Karasawa K; Sasaki T; Okawa T; Takahashi T; Hayakawa K; Ohizumi Y; Tamaki Y; Makino M; Kobyashi M; Shibayama C; Saitou T; Johnson DJ
    J Oncol Manag; 2003; 12(2):18-24. PubMed ID: 12699112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of salivary flow and dose-volume modeling of complication incidence in patients with head-and-neck cancer receiving intensity-modulated radiotherapy.
    Marzi S; Iaccarino G; Pasciuti K; Soriani A; Benassi M; Arcangeli G; Giovinazzo G; Benassi M; Marucci L
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1252-9. PubMed ID: 19251097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of intensity-modulated radiotherapy on health-related quality of life for head and neck cancer patients: matched-pair comparison with conventional radiotherapy.
    Graff P; Lapeyre M; Desandes E; Ortholan C; Bensadoun RJ; Alfonsi M; Maingon P; Giraud P; Bourhis J; Marchesi V; Mège A; Peiffert D
    Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1309-17. PubMed ID: 17289292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Grading xerostomia by physicians or by patients after intensity-modulated radiotherapy of head-and-neck cancer.
    Meirovitz A; Murdoch-Kinch CA; Schipper M; Pan C; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):445-53. PubMed ID: 16839705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of conventional radiotherapy on health-related quality of life and critical functions of the head and neck.
    Connor NP; Cohen SB; Kammer RE; Sullivan PA; Brewer KA; Hong TS; Chappell RJ; Harari PM
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1051-62. PubMed ID: 16682129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantifying radioxerostomia: salivary flow rate, examiner's score, and quality of life questionnaire.
    Al-Nawas B; Al-Nawas K; Kunkel M; Grötz KA
    Strahlenther Onkol; 2006 Jun; 182(6):336-41. PubMed ID: 16703289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation-induced xerostomia in patients with head and neck cancer: pathogenesis, impact on quality of life, and management.
    Chambers MS; Garden AS; Kies MS; Martin JW
    Head Neck; 2004 Sep; 26(9):796-807. PubMed ID: 15350026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.